Recursion Pharmaceuticals Inc is a biotechnology business based in the US. Recursion Pharmaceuticals shares (RXRX) are listed on the NASDAQ and all prices are listed in US Dollars. Recursion Pharmaceuticals employs 450 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Recursion Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RXRX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Recursion Pharmaceuticals stock price (NASDAQ: RXRX)
Use our graph to track the performance of RXRX stocks over time.Recursion Pharmaceuticals shares at a glance
Latest market close | $8.43 |
---|---|
52-week range | $4.92 - $42.81 |
50-day moving average | $6.57 |
200-day moving average | $12.94 |
Wall St. target price | $16.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.31 |
Buy Recursion Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Recursion Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Recursion Pharmaceuticals price performance over time
Historical closes compared with the close of $8.43 from 2022-07-01
1 week (2022-06-24) | -6.23% |
---|---|
1 month (2022-06-02) | 29.89% |
3 months (2022-04-01) | 9.62% |
6 months (2021-12-31) | -50.79% |
1 year (2021-07-02) | -77.03% |
---|---|
2 years (2020-06-28) | N/A |
3 years (2019-06-28) | N/A |
5 years (2017-06-28) | N/A |
Recursion Pharmaceuticals financials
Revenue TTM | $12.9 million |
---|---|
Gross profit TTM | $-125,093,000 |
Return on assets TTM | -25.87% |
Return on equity TTM | -59.74% |
Profit margin | 0% |
Book value | $2.89 |
Market capitalisation | $1.4 billion |
TTM: trailing 12 months
Recursion Pharmaceuticals share dividends
We're not expecting Recursion Pharmaceuticals to pay a dividend over the next 12 months.
Recursion Pharmaceuticals overview
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc. ; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals in the news
3 Cathie Wood Stocks That Could Deliver Monster Returns
Frequently asked questions
What percentage of Recursion Pharmaceuticals is owned by insiders or institutions?Currently 7.833% of Recursion Pharmaceuticals shares are held by insiders and 76.973% by institutions. How many people work for Recursion Pharmaceuticals?
Latest data suggests 450 work at Recursion Pharmaceuticals. When does the fiscal year end for Recursion Pharmaceuticals?
Recursion Pharmaceuticals's fiscal year ends in December. Where is Recursion Pharmaceuticals based?
Recursion Pharmaceuticals's address is: 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 What is Recursion Pharmaceuticals's ISIN number?
Recursion Pharmaceuticals's international securities identification number is: US75629V1044
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert